Association of polymorphisms within the tumour necrosis factor (TNF) genes and childhood asthma

Clinical and Experimental Allergy

Volumn 28, Issue 5, 1998, Pages 578-584

  Albuquerque, R V ^a   Hayden, C M ^a   Palmer, L J ^a   Laing, I A ^a   Rye, P J ^a   Gibson, N A ^a   Burton, P R ^b   Goldblatt, J ^c   Lesouef P N ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

Author keywords

Atopic asthma; Candidate gene; Lymphotoxin ; Polymorphism; TNF

Indexed keywords

HLA ANTIGEN CLASS 2; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ASTHMA; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOMODULATION; LUNG LAVAGE; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SPUTUM EXAMINATION;

EID: 0031838936     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1998.00273.x     Document Type: Article

References (40)

1. Rink L, Kirchner H. Recent progress in the Tumour Necrosis Factor alpha field. Int Arch Allergy Immunol 1996; 111:199-209.
2. Godfrey S. Airway inflammation, bronchial reactivity and asthma. [Rev] Agents Actions Suppl 1993; 40:109-43.
3. Hakonarson H, Herrick DJ, Serrano PG, Grunstein MM. Mechanism of cytokine-induced modulation of beta-adrenoceptor responsiveness in airway smooth muscle. J Clin Invest 1996; 97:2593-600.
4. Koizumi A, Hashimoto S, Kobayashi T et al. Elevation of serum soluble vascular cell adhesion molecule-1 (sVCAM-1) levels in bronchial asthma. Clin Exp Immunol 1995; 101:468-73.
5. Kebanoff SJ, Vadas MS, Harian JM et al. Stimulation of neutrophils by tumour necrosis factor. J Immunol 1986; 136: 4220-5.
6. Taki F, Torii K, Ikuta N et al. Increased levels of TNF concentrations in sputa of patients with bronchial asthma. Am Rev Respir Dis 1991; 143:A13 (abstract).
7. Broide DH, Lotz M, Cuomo AJ et al. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992; 89:958-67.
8. Bradding P, Roberts JA, Britten KM et al. Interleukin - 4, -5, and -6 and tumour necrosis factor alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471-80.
9. Ying S, Robinson DS, Varney V et al. TNFa mRNA expression in allergic inflammation. Clin Exp Allergy 1991; 21:745-50.
10. Gosset P, Tsicopoulos A, Wallaert B et al. Increased secretion of tumour necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol 1991; 88:561-71.
11. Shah A, Church MK, Holgate ST. Tumour necrosis factor alpha: a potential mediator of asthma. Clin Exp Allergy 1995; 25:1038-44.
12. Daniels SE, Bhattacharrya S, James A et al. A genome wide search for quantitative trait loci underlying asthma. Nature 1996; 383:247-50.
13. Carroll MC, Katzman P, Alicot EM et al. Linkage map of the human major histocompatibility complex including the tumour necrosis factor genes. Proc Natl Acad Sci USA 1987; 84:8535-9.
14. Wilson AG, de Vries N, Pociot F et al. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 1993; 177:557-60.
15. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human Tumour Necrosis Factor alpha (TNF-a) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992; 1:353.
16. Wilson AG, Symons JA, McDowell TL, di Giovine FS, Duff GW. Effects of a tumour necrosis factor (TNFα) promoter base transition on transcriptional activity. Br J Rheumatol 1994; 33:89.
17. Brinkman BMN, Zuijdgeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor alpha (TNFα) -308 promoter polymorphism in (TNFα) gene regulation. J Inflamm 1996; 46:32-41.
18. Stuber F, Udalova IA, Book M et al. -308 Tumor Necrosis Factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccaride inducibility of the human TNF promoter. J Inflamm 1996; 46:42-50.
19. Chen G, Wilson R, Wang SH et al. Tumour necrosis factor-alpha (TNFα) gene polymorphism and expression in preeclampsia. Clin Exp Immunol 1996; 104:154-9.
20. Pociot F, Wilson AG, Nerup J, Duff GW. No independent association between a tumor necrosis factor alpha promoter polymorphism and insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23:3050-3.
21. Wilson AG, van deVries N, de Putte LBA, Duff GW. A tumour necrosis factor alpha polymorphism is not associated with rheumatoid arthritis. Ann Rheum Dis 1995; 54:601-3.
22. Cabrera M, Shaw MA, Sharples C et al. Polymorphism in tumor necrosis factor genes associated with Mucocutaneous Leishmaniasis. J Exp Med 1995; 182:1259-64.
23. Bouma G, Zia B, Crusius JBA et al. Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patient with inflammatory bowel disease (IBD). Clin Exp Immunol 1996; 103:391-6.
24. Fugger L, Morling N, Ryder LP et al. NcoI restriction fragment length polymorphism (RFLP) of the tumour necrosis factor (TNFα) region in primary biliary cirrhosis and in healthy Danes. Scand J Immunol 1989; 30:185-9.
25. Badenhoop K, Schwartz G, Trowsdale J et al. TNFα gene polymorphisms in type I (insulin-dependent) diabetes mellitus. Diabetiologia 1989; 32:445-8.
26. Fugger L, Morling N, Ryder LP et al. NcoI restriction fragment length polymorph (RFLP) of the tumor necrosis factor (TNFα) region in four antoimmune diseases. Tissue Antigens 1989; 34:17-22.
27. Young S, LeSouëf PN, Geelhoed GC et al. The influence of a family history of asthma and parental smoking on airway responsiveness in early infancy. New Engl J Med 1991; 324: 1168-73.
28. Yan K, Salome C, Woolcock A. Rapid method of measurement of bronchial responsiveness. Thorax 1983; 38:760-5.
29. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: A laboratory manual, 2nd edn. 1989; Cold Spring Harbor Laboratory Press.
30. Messer G, Spengler U, Jung MC et al. Polymorphic structure of the tumour necrosis factor (TNF) locus: and NcoI polymorphism in the first intron of the human TNF-β gene correlates with a variant aminoacid in position 26 and reduced level of TNF-β production. J Exp Med 1991; 173:209-19.
31. Moffatt MF, Cookson WOCM. Tumour necrosis factor haplo-types and asthma. Hum Mol Genet 1997; 6:551-4.
32. Li Cam Wa TC, Mansur AH, Lewis S et al. Association of TNF promoter polymorphisms with BHR. analysis of extended MHC haplotypes. Am J Resp Crit Care Med 1997; 155:A701.
33. Campbell DA, Britton J, Pavord I et al. LTα NcoI polymorphism at the TNF locus correlates with clinical symptoms of asthma. Eur Resp J 1995; 8:552s.
34. Pociot F, Molvig J, Wogensen L et al. A tumour necrosis factor-β gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus. Sand J Immunol 1991; 33:37-49.
35. Molvig J, Pociot F, Back L et al. Monocyte function in IDDM patients and healthy individuals. Scand J Immumol 1990; 32: 297-311.
36. Han J, Lee JD, Bibbs L, Ulevitch RJ. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Sci 1994; 265:808-11.
37. Lee JC, Laydon JT, McDonnell PC et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372:739-46.
38. McDonnell PC, DiLella AG, Lee JC, Young PR. Localisation of the human stress responsive MAP kinase-like CSAIDs binding protein (CSBP) gene to chromosome 6p21.3/21.2 Genomics 1995; 29:301-2.
39. Albertella MR, Campbell RD. Characteriszation of a novel gene in the human major histocompatibility complex that encodes a potential new member of the I kappa B family of proteins. Hum Mol Genet 1994; 3:793-9.
40. Holzinger I, de Baey A, Messer G et al. Cloning and genomic characterization of LST1: A new gene in the human TNF region. Immunogenetics 1995; 42:315-22.